Welcome to LookChem.com Sign In|Join Free

CAS

  • or
methyl 3-fluoro-2-(4-formyl-3-methylpyrazol-1-yl)benzoate is a chemical with a specific purpose. Lookchem provides you with multiple data and supplier information of this chemical.

1307314-07-3

Post Buying Request

1307314-07-3 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

1307314-07-3 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 1307314-07-3 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,3,0,7,3,1 and 4 respectively; the second part has 2 digits, 0 and 7 respectively.
Calculate Digit Verification of CAS Registry Number 1307314-07:
(9*1)+(8*3)+(7*0)+(6*7)+(5*3)+(4*1)+(3*4)+(2*0)+(1*7)=113
113 % 10 = 3
So 1307314-07-3 is a valid CAS Registry Number.

1307314-07-3Relevant articles and documents

Discovery of a novel series of orally active nociceptin/orphanin FQ (NOP) receptor antagonists based on a dihydrospiro(piperidine-4,7′-thieno[2,3- C ]pyran) scaffold

Toledo, Miguel A.,Pedregal, Concepción,Lafuente, Celia,Diaz, Nuria,Martinez-Grau, Maria Angeles,Jiménez, Alma,Benito, Ana,Torrado, Alicia,Mateos, Carlos,Joshi, Elizabeth M.,Kahl, Steven D.,Rash, Karen S.,Mudra, Daniel R.,Barth, Vanessa N.,Shaw, David B.,McKinzie, David,Witkin, Jeffrey M.,Statnick, Michael A.

supporting information, p. 3418 - 3429 (2014/05/20)

Nociceptin/OFQ (N/OFQ) is a 17 amino acid peptide that is the endogenous ligand for the ORL1/NOP receptor. Nociceptin appears to regulate a host of physiological functions such as biological reactions to stress, anxiety, mood, and drug abuse, in addition

SPIROPIPERIDINE COMPOUNDS AS ORL-1 RECEPTOR ANTAGONISTS

-

Page/Page column 27, (2011/06/16)

An ORL-1 receptor antagonist of the formula: its uses, and methods for its preparation are described. ORL-1 antagonists are deemed to be useful in the treatment of depression and/or the treatment of overweight, obesity, and/or weight maintenance post treatment for overweight or obesity. Certain compounds have also demonstrated through animal models that the compounds of the present invention are useful for the treatment of migraines.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 1307314-07-3